Literature DB >> 25179346

Ablation of experimental colon cancer by intratumoral 224Radium-loaded wires is mediated by alpha particles released from atoms which spread in the tumor and can be augmented by chemotherapy.

Shira Reitkopf-Brodutch1, Hila Confino, Michael Schmidt, Tomer Cooks, Margalit Efrati, Lior Arazi, Lea Rath-Wolfson, Gideon Marshak, Itzhak Kelson, Yona Keisari.   

Abstract

PURPOSE: We developed (224)Ra-loaded wires, which release by recoil alpha emitting nuclei into solid tumors and cause tumor cell killing. This research examined if the major damage was inflicted by alpha particles emitted from these atoms or by direct gamma and beta emissions from the inserted wires. We also examined the efficacy of this treatment against colon cancer in combination with chemotherapy.
MATERIALS AND METHODS: Mouse colon carcinomas (CT-26 xenografts), treated by intra-tumoral radioactive wires loaded with (224)Ra atoms were monitored for effects on tumor growth, intratumoral tissue damage and distribution of alpha emitting atoms. The effects were compared with those of (224)Ra-loaded wires coated with poly methyl methacrylate (PMMA), which blocks atom recoil. Similar experiments were performed with radioactive wires combined with systemic 5-FU.
RESULTS: (224)Ra-loaded wires inhibited tumor growth and formed necrotic areas inside the tumor. PMMA coated wires did not inhibit tumor growth, and caused minor intratumoral damage. Autoradiography images of tumors treated with (224)Ra-loaded wires revealed a spread of alpha emitters over several mm, whereas PMMA-coated wires showed no such spread. Injection of 5-FU with (224)Ra-loaded wires augmented tumor growth retardation and cure.
CONCLUSIONS: (224)Ra-loaded wires ablate solid tumors by the release of alpha-particle emitting atoms inside the tissue, an effect that can be enhanced by combining this method with chemotherapy.

Entities:  

Keywords:  224Ra; 5-FU; Colon cancer; brachytherapy; chemotherapy; radiotherapy

Mesh:

Substances:

Year:  2015        PMID: 25179346     DOI: 10.3109/09553002.2015.959666

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  2 in total

Review 1.  Atomic Nanogenerators in Targeted Alpha Therapies: Curie's Legacy in Modern Cancer Management.

Authors:  Mareike Roscher; Gábor Bakos; Martina Benešová
Journal:  Pharmaceuticals (Basel)       Date:  2020-04-23

2.  Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.

Authors:  Yossi Nishri; Maayan Vatarescu; Ishai Luz; Lior Epstein; Mirta Dumančić; Sara Del Mare; Amit Shai; Michael Schmidt; Lisa Deutsch; Robert B Den; Itzhak Kelson; Yona Keisari; Lior Arazi; Tomer Cooks; Vered Domankevich
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.